enVVeno Medical Corporation (NASDAQ: NVNO)
$2.8200
N/A ( -3.09% ) 109.7K
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Market Data
Open
$2.8200
Previous close
$2.8200
Volume
109.7K
Market cap
$49.45M
Day range
$2.7850 - $2.9350
52 week range
$2.4500 - $6.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 44 | Oct 31, 2024 |
8-k | 8K-related | 18 | Sep 30, 2024 |
10-q | Quarterly Reports | 42 | Jul 31, 2024 |
10-q | Quarterly Reports | 46 | May 08, 2024 |
8-k | 8K-related | 15 | Apr 24, 2024 |
4 | Insider transactions | 1 | Mar 15, 2024 |
8-k | 8K-related | 16 | Mar 06, 2024 |
10-k | Annual reports | 71 | Feb 29, 2024 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |